WASHINGTON, DC, July 8, 2015 – The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the regenerative medicine and advanced therapies community, announced it will hold its annual Stem Cell Meeting on the Mesa. The conference is the sector’s premiere forum bringing together senior executives and top decision makers in the industry with the scientific community with the shared goal of advancing and translating cutting-edge research into revolutionary treatments and cures.
This year’s event will take place October 7-9, 2015 in La Jolla, California and will attract nearly 800 attendees, including leading cell therapy, gene therapy and tissue engineering companies, large pharma and biotech, industry investors and major academic research institutions.
“The regenerative medicine and advanced therapies sector has expanded significantly over the past few years, highlighting the importance of this conference with its unique focus on our community,” said Edward Lanphier, president & CEO of Sangamo BioSciences and chairman of ARM. “This meeting offers the opportunity to discuss recent advances and key issues in the field and to foster important relationships that are essential to moving these novel therapies through clinical trials and to patients with unmet medical needs.”
Co-hosted by ARM, the California Institute for Regenerative Medicine (CIRM) and the Sanford Consortium for Regenerative Medicine, this three-day conference features three distinct parts, the program’s two-day Partnering Forum, a Public Forum lecture and a full-day Scientific Symposium.
During the fifth annual Partnering Forum, October 7-8, industry executives will lead in-depth, interactive panels and workshops to discuss critical commercial issues facing the sector. More than 50 leading companies will highlight their clinical and commercial progress to interested partners and investors and more than 700 one-on-one meetings will be scheduled using the EBD Group’s state-of-the-art partneringONE® software.
Following the close of the Partnering Forum on October 8, there will be a Public Forum and Reception held at the Sanford Consortium for Regenerative Medicine. This lecture, which is open to the general public and aimed at fostering relationships between the public, industry and academia, will feature a top clinician in the space whose research is poised to become a commercialized product.
The 10th annual Scientific Symposium will take place on October 9 at the Salk Institute for Biological Studies. This program will feature four panel discussions led by international leading scientists, as well as two keynote presentations by world-renowned researchers. More than 40 posters featuring the latest scientific discoveries will also be on display throughout the day.
The event’s detailed agenda will be updated regularly on the event website.
Registration is now open, with discounted early-bird rates available through August 28. Registration is complimentary for investors and credentialed members of the media. To learn more and to register, please visit www.stemcellmeetingonthemesa.com. For members of the media interested in attending, please contact Lyndsey Scull at firstname.lastname@example.org.
For interested organizations looking to increase exposure to this field’s top decision-makers via sponsorship, please contact Laura Parsons at email@example.com for additional information.
About The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, D.C. to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 220 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.
# # #